Philippines
11 Vaccines Approved for Use in Philippines
Protein Subunit
Serum Institute of India
COVOVAX (Novavax formulation)
Approved in 5 countries
3 trials in 1 country
Approval Source: reuters.com
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
80 trials in 26 countries
Approval Source: bloomberg.com
RNA
Non Replicating Viral Vector
Gamaleya
Sputnik Light
Approved in 26 countries
6 trials in 2 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
63 trials in 30 countries
Approval Source: bloomberg.com
Inactivated
Bharat Biotech
Covaxin
Approved in 14 countries
13 trials in 2 countries
Approval Source: reuters.com
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 91 countries
29 trials in 12 countries
Approval Source: bloomberg.com
Inactivated
Sinopharm (Wuhan)
Inactivated (Vero Cells)
Approved in 2 countries
9 trials in 7 countries
Approval Source: fda.gov.ph
Inactivated
9 in Clinical Trials in Philippines
Protein Subunit
Clover
SCB-2019
12 trials in 11 countries
Protein Subunit
Livzon Mabpharm Inc
V-01
7 trials in 3 countries
Protein Subunit
SK Bioscience Co Ltd
GBP510
6 trials in 6 countries
Protein Subunit
West China Hospital
Recombinant (Sf9 cell)
7 trials in 4 countries
DNA
Inovio
INO-4800
9 trials in 9 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
63 trials in 30 countries
Replicating Viral Vector
Wantai
DelNS1-2019-nCoV-RBD-OPT1
5 trials in 3 countries
Inactivated
Sinovac
CoronaVac
Approved in 56 countries
37 trials in 9 countries